NASDAQ: AEMD · Industrial Applications and Services · 8 alerts · CIK 882291
Share price
$5.01Close, Nov 16
Market cap
$8.05M
Shares outstanding
1.61MLatest SEC cover page
Sector
Industrial Applications and Services
Industry
Surgical & Medical Instruments & ApparatusSIC 3841
Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Aethlon Medical Inc filings on SEC EDGAR ↗
Aethlon Medical M&A Deal with North Immunology, Inc.
Aethlon Medical provided a status update on its pending merger with North Immunology, Inc., originally announced on September 17, 2026. The filing includes an updated investor presentation that North Immunology will use in meetings with investors regarding the transaction and a concurrent private placement.
Aethlon Medical Signs $150M M&A Deal with North Immunology, Inc.
Aethlon Medical (AEMD) has entered into a definitive agreement to acquire North Immunology in an all-stock merger transaction valued at a framework of $150 million for the target. Concurrent with the merger, North Immunology secured an oversubscribed $180 million private placement from a syndicate of healthcare investors to fund operations into 2028. The combined company will focus on advancing NOR-101, a bispecific antibody for atopic dermatitis, and will trade under the new ticker NRTX.